Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Aug 30, 2007
Boston Scientific Corporation (NYSE: BSX) today announced that three of its subsidiaries, Guidant Corporation, Cardiac Pacemakers Inc. and Guidant...
-
Aug 29, 2007
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the European...
-
Aug 28, 2007
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bear Stearns 20th Annual Healthcare Conference, which is being held...
-
Aug 23, 2007
Boston Scientific Corporation (NYSE: BSX) today announced that it has successfully amended its $2 billion revolving line of credit and $5 billion...
-
Aug 16, 2007Transaction Would Advance Company's Plan to Divest Non-Strategic Assets and Strengthen Operating and Financial Performance
Boston Scientific Corporation (NYSE: BSX) today announced its intention to explore the sale of its Cardiac Surgery and Vascular Surgery businesses...
-
Aug 9, 2007BSC to assume sole control of Pain Management business and emerging indications program, Advanced Bionics principals to purchase Auditory business and drug pump program
Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into an agreement to amend its merger agreement with Advanced Bionics,...
-
Aug 2, 2007Endosurgery group to remain wholly owned by Boston Scientific
Boston Scientific Corporation (NYSE: BSX) today provided an update on its plans to strengthen operating and financial performance as part of its...
-
Jul 24, 2007
Boston Scientific Corporation (NYSE: BSX) today announced its intention to explore the sale of its fluid management business as part of the...
-
Jul 20, 2007
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the second quarter ended June 30, 2007, as well as guidance for net...
-
Jul 19, 2007TAXUS PERSEUS clinical program to evaluate platinum enhanced drug-eluting stent
Boston Scientific Corporation (NYSE: BSX) today announced the beginning of clinical trial enrollment in studies evaluating its third-generation...